|
AACR/ASCO Presidential Symposium – Learning from Our Children: New Insights in Pediatric Oncology
Co-Chairpersons: Judy E. Garber, AACR President, Dana-Farber Cancer Institute, Boston, MA; and Michael P. Link, ASCO President, Stanford University, Palo Alto, CA
- Smita Bhatia, City of Hope, Duarte, CA
- James R. Downing, St. Jude Children's Research Hospital, Memphis, TN
- Judy E. Garber
- Michael P. Link
- Ching-Hon Pui, St. Jude Children's Research Hospital, Memphis, TN
Autophagy and Cancer
Chairperson: Eileen P. White, UMDNJ-The Cancer Institute of New Jersey, New Brunswick, NJ
- Jun-Lin Guan, University of Michigan, Ann Arbor, MI
- Kevin Ryan, Beatson Institute for Cancer Research, Glasgow, United Kingdom
- Eileen P. White
- Junying Yuan, Harvard Medical School, Boston, MA
The Bayard D. Clarkson Symposium on Stem Cells and Cancer: Stem Cells, Self-Renewal, and Cancer
Chairperson: Sean J. Morrison, Children's Research Institute at UT Southwestern, Dallas, TX
- Scott A. Armstrong, Children's Hospital Boston, Boston, MA
- Ravindra Majeti, Stanford University, Stanford, CA
- Sean J. Morrison
- Benjamin G. Neel, Ontario Cancer Institute, Princess Margaret Hospital, Toronto, ON, Canada
Biologic Factors Associated With Cancer Disparities
Chairperson: Xifeng Wu, The University of Texas MD Anderson Cancer Center, Houston, TX
- Adeyinka O. Laiyemo, National Cancer Institute, Bethesda, MD
- Carol J. Etzel, The University of Texas MD Anderson Cancer Center, Houston, TX
- Lisa A. Newman, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
- Peng Lee, New York University School of Medicine, New York, NY
Can Cancer Prevention Be Individualized?
Chairperson: Gad Rennert, CHS National Cancer Control Center, Haifa, Israel
- Zvi Livneh, Weizmann Institute of Science, Rehovot, Israel
- John Mathers, Human Nutrition Research Centre, Newcastle upon Tyne, United Kingdom
- Gad Rennert
- Margaret R. Spitz, The University of Texas MD Anderson Cancer Center, Houston, TX
Cell and Tissue Size Control in Cancer
Chairperson: John Blenis, Harvard Medical School, Boston, MA
- Liliana Attisano, University of Toronto, Toronto, ON, Canada
- John Blenis
- Kun-Liang Liang Guan, UCSD Moores Cancer Center, La Jolla, CA
- Brendan D. Manning, Harvard School of Public Health, Boston, MA
Chromatin and the Epigenome as Drug Targets
Chairperson: Cheryl Arrowsmith, University of Toronto Ontario Cancer Institute, Toronto, ON, Canada
- Cheryl Arrowsmith
- James E. Bradner, Dana-Farber Cancer Institute, Boston, MA
- Dash Dhanak, GlaxoSmithKline, Collegeville, PA
- Victoria M. Richon, Epizyme, Inc., Cambridge, MA
Clinical Trial Design in the Era of High-Density Data Analysis
Chairperson: Yu Shyr, Vanderbilt-Ingram Cancer Center, Nashville, TN
- Tona M. Gilmer, GlaxoSmithKline, Research Triangle Park, NC
- Yu Shyr
- Lillian L. Siu, University Health Network Ontario Cancer Institute, Toronto, ON, Canada
- Markus Warmuth, H3 Biomedicine, Inc., Cambridge, MA
Control of Metabolic Pathways and Cancer
Chairperson: Reuben J. Shaw, Salk Institute for Biological Studies, La Jolla, CA
- Joan S. Brugge, Harvard Medical School, Boston, MA
- Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom
- Reuben J. Shaw
- Craig B. Thompson, Memorial Sloan-Kettering Cancer Center, New York, NY
Designing Rational Combination Therapy for Cancer
Chairperson: Michael B. Yaffe, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
- Douglas A. Lauffenburger, Massachusetts Institute of Technology, Cambridge, MA
- Sylvia K. Plevritis, Stanford University, Stanford, CA
- Brent R. Stockwell, Columbia University, New York, NY
- Joshua M. Stuart, University of California, Santa Cruz, CA
Determining the Cell of Origin in Cancers
Chairperson: Jane E. Visvader, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
- Anton Berns, The Netherlands Cancer Institute, Amsterdam, The Netherlands
- Cedric Blanpain, Université Libre de Bruxelles, Bruxelles, Belgium
- Martine F. Roussel, St. Jude Children's Research Hospital, Memphis, TN
- Jane E. Visvader
Developmental Pathways in Cancer
Chairperson: Jeffrey Wrana, University of Toronto, Toronto, ON, Canada
- Frederic J. De Sauvage, Genentech, Inc., South San Francisco, CA
- Senthil K. Muthuswamy, University of Toronto Ontario Cancer Institute, Toronto, ON, Canada
- Jeremy Reiter, University of California, San Francisco, CA
- Jeffrey Wrana
DNA Damage Repair and Cancer Therapy
Chairperson: Alan D. D’Andrea, Dana-Farber Cancer Institute, Boston, MA
- Mary Helen Barcellos-Hoff, New York University, New York, NY
- Alan D. D'Andrea
- Andre Nussenzweig, National Cancer Institute, Bethesda, MD
- Tanya T. Paull, University of Texas at Austin, Austin, TX
Dormant and Stem Cells in Tumor Heterogeneity
Chairperson: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA
- Julio A. Aguirre-Ghiso, Mount Sinai School of Medicine, New York, NY
- Meenhard Herlyn, The Wistar Institute, Philadelphia, PA
- Kornelia Polyak, Dana-Farber Cancer Institute, Boston, MA
- Andreas Trumpp, Heidelberg Institute for Stem Cell Technology and Experimental Medicine, Heidelberg, Germany
Genetics and Epigenetics of Hematologic Malignancies
Chairperson: Olivier A. Bernard, Institut Gustave-Roussy, Villejuif, France
- Olivier A. Bernard
- Sai-Juan Chen, Shanghai Institute of Hematology, Shanghai, China
- Brian Huntly, University of Cambridge, Cambridge, United Kingdom
- Yue Xiong, University of North Carolina at Chapel Hill, Chapel Hil, NC
Genomic Integrity in Cancer
Chairperson: Karlene A. Cimprich, Stanford University, Stanford, CA
- Angelika Amon, Massachusetts Institute of Technology, Cambridge, MA
- Karlene A. Cimprich
- Anindya Dutta, University of Virginia Health System, Charlottesville, VA
- Óscar Fernández-Capetillo, Spanish National Cancer Research Center, Madrid, Spain
- Jan Karlseder, Salk Institute for Biological Studies, La Jolla, CA
Genomics and Progression of Metastasis
Chairperson: Kari K. Alitalo, University of Helsinki, Helsinki, Finland
- Kari K. Alitalo
- Christine A. Iacobuzio-Donahue, Johns Hopkins Hospital, Baltimore, MD
- Michael Karin, University of California San Diego, La Jolla, CA
- Michael R. Stratton, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
Hypoxia: ROS and the Response to Therapy
Chairperson: M. Celeste Simon, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
- Navdeep S. Chandel, Northwestern University, Chicago, IL
- Amato J. Giaccia, Stanford University School of Medicine, Stanford, CA
- Gregg L. Semenza, Johns Hopkins University, Baltimore, MD
- M. Celeste Simon
Immune Cell Function and Cancer In Vivo: Visualizing Friends and Foes
Chairperson: Christopher H. Contag, Stanford University School of Medicine, Stanford, CA
- John S. Condeelis, Sr., Albert Einstein College of Medicine, Bronx, NY
- Christopher H. Contag
- I. Jolanda M. De Vries, Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands
- Charles Lin, Massachusetts General Hospital, Boston, MA
Impact of Brain-Immune System Interactions on Cancer Development and Health-Related Quality of Life
Chairperson: Andrew Miller, Emory University, Atlanta, GA
- Julienne Bower, UCLA Cousins Center for Psychoneuroimmunology, Los Angeles, CA
- Firdaus S. Dhabhar, Stanford University, Stanford, CA
- Andrew Miller
- Leah M. Pyter, University of Illinois at Chicago, Chicago, IL
In Vivo Systems Biology: Modeling Regulatory Networks in the Mouse
Chairperson: Lynda Chin, The University of Texas MD Anderson Cancer Center, Houston, TX
- David Adams, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
- Amy Brock, Harvard University, Brookline, MA
- Lynda Chin
- Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
Influence of Energy Balance and Obesity on Cancer Disparities:
The MICR Scientific Symposium
Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA; and Amelie G. Ramirez, The University of Texas Health Science Center at San Antonio, San Antonio, TX
- Wendy Demark-Wahnefried, The University of Texas MD Anderson Cancer Center, Houston, TX
- Rong Li, The University of Texas Health Science Center at San Antonio, San Antonio, TX
- Steven D. Mittelman, USC/Childrens Hospital Los Angeles, Los Angeles, CA
- Kathryn H. Schmitz, University of Pennsylvania, Philadelphia, PA
Integrative Functional Genomics
Chairperson: William C. Hahn, Dana-Farber Cancer Institute, Boston MA
- William C. Hahn
- Michael T. Hemann, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
- Scott W. Lowe, Memorial Sloan-Kettering Cancer Center, New York, NY
- Jason Moffat, University of Toronto, Toronto, ON, Canada
- Michael A. White, UT Southwestern Medical Center, Dallas, TX
Interrogating Antitumor Immunity
Chairperson: Pamela S. Ohashi, University of Toronto Ontario Cancer Institute, Toronto, ON, Canada
- Jerome Galon, INSERM U255, Paris, France
- Francesco M. Marincola, National Institutes of Health Clinical Center, Bethesda, MD
- Pamela S. Ohashi
- Jedd D. Wolchok, Memorial Sloan-Kettering Cancer Center, New York, NY
Interrogating the Logic of the Cancer Cell: Lessons From Integrative and Systems Biology Approaches
Chairperson: Douglas A. Lauffenburger, Massachusetts Institute of Technology, Cambridge, MA
- Andrea Califano, Columbia University, New York, NY
- Ernest Fraenkel, Massachusetts Institute of Technology, Cambridge, MA
- Franziska Michor, Dana-Farber Cancer Institute, Boston, MA
- Claire Tomlin, University of California, Berkeley, CA
Medicines Targeting Genetic Alterations
Chairperson: Nathanael S. Gray, Dana-Farber Cancer Institute, Boston, MA
- Gideon Bollag, Plexxikon, Inc., Berkeley, CA
- James G. Christensen, Pfizer, Inc., La Jolla, CA
- Nathanael S. Gray
- John Kuriyan, University of California, Berkeley, CA
Metastasis-Initiating Cells and Niches
Chairperson: Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY
- Elaine V. Fuchs, Rockefeller University, New York, NY
- Joan Massagué
- David T. Scadden, Massachusetts General Hospital, Boston, MA
- Ben Z. Stanger, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
Microbiome, Viruses, and Cancer
Chairperson: Anna R. Giuliano, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
- Martin J. Blaser, New York University Medical Center, New York, NY
- Anna R. Giuliano
- Allan Hildesheim, National Cancer Institute, Bethesda, MD
- Julie Parsonnet, Stanford University School of Medicine, Stanford, CA
microRNAs and Cancer
Chairperson: Yibin Kang, Princeton University, Princeton, NJ
- Thomas Brabletz, University of Freiburg, Frieburg, Germany
- George A. Calin, The University of Texas MD Anderson Cancer Center, Houston, TX
- Yibin Kang
- Sohail Tavazoie, Rockefeller University, New York, NY
Modulating Antitumor Responses by Stromal Cells and Innate Immunity
Chairperson: Jeffrey W. Pollard, Albert Einstein College of Medicine, Bronx, NY
- Nina Bhardwaj, New York University School of Medicine, New York, NY
- Douglas T. Fearon, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom
- Jeffrey W. Pollard
- Robert H. Vonderheide, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
Molecular Imaging in Cancer Therapy: Functionalizing the Cancer Genome
Chairperson: David Piwnica-Worms, Washington University School of Medicine, St. Louis, MO
- James P. Basilion, Case Western Reserve University, Cleveland, OH
- Steven M. Larson, Memorial Sloan-Kettering Cancer Center, New York, NY
- David Piwnica-Worms
- Martin G. Pomper, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
Mouse Models for Gene Discovery, Prevention, and Treatment
Chairperson: Guillermina Lozano, The University of Texas MD Anderson Cancer Center, Houston, TX
- Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY
- Guillermina Lozano
- Owen J. Sansom, Beatson Institute for Cancer Research, Glasgow, United Kingdom
- David A. Tuveson, Cancer Research UK Cambridge Research Institute, Cambridge, United Kingdom
Nontraditional Targets of Small-Molecule Therapeutics: Emerging Technologies in the Post-Antibody Era
Chairperson: Hiroaki Suga, University of Tokyo, Tokyo, Japan
- Anthony A. Kossiakoff, University of Chicago, Chicago, IL
- Hiroaki Suga
- Gregory L. Verdine, Harvard University, Cambridge, MA
- Gregory Winter, Medical Research Council, Cambridge, United Kingdom
Pediatric Cancer Genomics: Honoring St. Jude Children’s Research Hospital’s 50th Anniversary
Chairperson: James R. Downing, St. Jude Children’s Research Hospital, Memphis, TN
- John M. Maris, Children's Hospital of Philadelphia, Philadelphia, PA
- Charles G. Mullighan, St. Jude Children's Research Hospital, Memphis, TN
- Michael D. Taylor, University of Toronto Hospital for Sick Children, Toronto, ON, Canada
- Jinghui Zhang, St. Jude Children's Research Hospital, Memphis, TN
Post-GWAS Functional Characterization of Cancer Risk Loci
Chairperson: Matthew L. Freedman, Dana-Farber Cancer Institute, Boston, MA
- Stephen J. Chanock, National Cancer Institute, Bethesda, MD
- Thomas J. Hudson, Ontario Institute for Cancer Research, Toronto, ON, Canada
- Nazneen Rahman, Institute of Cancer Research, Sutton, United Kingdom
- John Stamatoyannopoulos, University of Washington, Seattle, WA
Posttranslational Modifications in DNA Repair
Chairperson: Daniel Durocher, University of Toronto Ontario Cancer Institute, Toronto, ON, Canada
- Daniel Durocher
- Ronald T. Hay, University of Dundee, Dundee, United Kingdom
- Helle Ulrich, Cancer Research UK London Research Institute, South Mimms, United Kingdom
- Michael B. Yaffe, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
Protein Tyrosine Phosphatases and Cancer
Chairperson: Nicholas K. Tonks, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
- Trever G. Bivona, University of California, San Francisco, CA
- Nicholas K. Tonks
- Thomas F. Westbrook, Baylor College of Medicine, Houston, TX
- Wentain Yang, Brown University Alpert Medical School, Providence, RI
The Ras/Raf Pathway in Cancer
Chairperson: Deborah Morrison, National Cancer Institute, Frederick, MD
- Christopher J. Marshall, Institute of Cancer Research, London, United Kingdom
- Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- Deborah Morrison
- Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY
The Ruth Sager Memorial Symposium on Cancer Genetics and Epigenetics: Chromatin, Transcriptional Regulation and Cancer
Chairperson: Trevor K. Archer, National Institute of Environmental Health Sciences, Research Triangle Park, NC
- Trevor K. Archer
- Myles Brown, Dana-Farber Cancer Institute, Boston, MA
- Andrew P. Feinberg, Johns Hopkins University School of Medicine, Baltimore, MD
- P. Andrew Futreal, Wellcome Trust Sanger Institute, Cambridge, United Kingdom
Screening and Cancer Prevention in Underdeveloped Environments
Chairperson: Eduardo Cazap, Latin American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, Argentina
- Laurence H. Baker, University of Michigan, Ann Arbor, MI
- Eduardo Cazap
- Mei-Hwei Chang, National Taiwan University Hospital, Taipei, Taiwan
- Surendra S. Shastri, Tata Memorial Hospital, Mumbai, India
The Stanley J. Korsmeyer Memorial Symposium: Programmed Necrosis
Chairperson: Douglas R. Green, St. Jude Children’s Research Hospital, Memphis, TN
- Alexei Degterev, Tufts University School of Medicine, Boston, MA
- Douglas R. Green
- Peter Vandenabeele, University of Gent, Gent, Belgium
- Xiaodong Wang, National Institute of Biological Sciences, Beijing, China
Stem Cells and Epigenetics
Chairperson: Bradley E. Bernstein, Massachusetts General Hospital, Boston, MA
- Bradley E. Bernstein
- Kristian Helin, University of Copenhagen, Copenhagen, Denmark
- Alea A. Mills, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
- Maarten Van Lohuizen, Netherlands Cancer Institute, Amsterdam, The Netherlands
Tumor Extracellular Matrix: An Emerging Target for Therapies
Chairperson: Richard O. Hynes, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA
- Richard O. Hynes
- Ilaria Malanchi, Cancer Research UK London Research Institute, London, United Kingdom
- Dario Neri, ETH Zürich, Zürich, Switzerland
- Valerie M. Weaver, University of California Medical Center, San Francisco, CA
Vascular Reprogramming to Improve Clinical Outcome
Chairperson: Lena Claesson-Welsh, Uppsala University, Uppsala, Sweden
- Lena Claesson-Welsh
- Enrico Giraudo, Institute for Cancer Research and Treatment (IRCC), University of Turin, Candiolo, Italy
- Donald M. McDonald, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
- Inder M. Verma, Salk Institute for Biological Studies, La Jolla, CA
Visualizing the Metabolic Environment of Tumors
Chairperson: Sarah J. Nelson, University of California, San Francisco, CA
- Zaver M. Bhujwalla, Johns Hopkins University School of Medicine, Baltimore, MD
- Murali Krishna Cherukuri, National Cancer Institute, Bethesda, MD
- Kenneth A. Krohn, University of Washington, Seattle, WA
- Sarah J. Nelson
|